Aine Marie Kelly
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Aine Marie Kelly has a total of 129 co-authors. Here are the top co-authors by number of shared publications:
- Marina A. Lynch
Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland
16 shared publications - Amy M. Birch
Division of Brain Sciences, Hammersmith Hospital, Imperial College London, London, UK
4 shared publications - Charlotte K. Callaghan
Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin 2, Ireland
4 shared publications C. Maguire
Physiology Department, Trinity College, Dublin, Ireland
3 shared publications- Eadaoin W. Griffin
School of Biochemistry and Immunology & Trinity College Institute of Neuroscience, Dublin 2, Ireland
3 shared publications Emily Vereker
3 shared publications
Latest Publications
- Open Access
- 5 December 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (12) , e0327408
The influence of type 2 diabetes and its metabolic correlates in middle-aged adults on cognition at mid and later life; A systematic review and meta-analysis
Introduction: While previous studies have examined the link between Type 2 Diabetes Mellitus (T2DM) and cognitive function in middle-aged adults, no review has explored the long-term effects on cognition of T2DM when diagnosed at midlife. This review aims to investigate any association between T2DM and its metabolic correlates during midlife and measures of cognitive function, spanning from midlife into later life. Methods: Electronic databases (EMBASE, Medline, CINAHL, Web of Science) were explored from their establishment until December 2023 to identify studies exploring the link between T2DM in midlife (40–65 years) and cognitive function. T2DM was defined based on ESC and AHA criteria, encompassing diabetes status, FBG, HbA1c levels, and MetS presence. Cognitive function in mid and/or later life was categorised into functioning sub-domains, with tests selected to reflect predominant cognitive functions utilised. A random-effects meta-analysis was performed, and study quality assessed using the AXIS tool. Results: We included 151 studies of moderate to high quality. Studies were independently screened in a step-by-step process, with a subset of studies that met the criteria selected for inclusion in a meta-analysis. Due to limited availability of raw data for cognitive measures at later life, meta-analysis was conducted on studies assessing cognitive function at midlife only. In the case of later life, the majority of longitudinal studies reported negative relationships between midlife T2DM and cognitive function, specifically in the modalities of executive function and global cognition; findings for memory were conflicting. Qualitive assessment of 107 studies where cognitive function was assessed at midlife found no association between it and midlife T2DM. However, meta-analysis of 10 studies revealed a negative impact of T2DM on memory (MD = −0.19; 95% CI = −0.26 to −0.11; I2 = 25%), executive function (MD = −0.14; 95% CI = −0.25 to −0.04; I2 = 0%), and global cognition (MD = −0.26; 95% CI = −0.34 to −0.17; I2 = 0%). Discussion: This study highlights the impact of midlife T2DM on a variety of cognitive domains from midlife onwards, suggesting that timely diagnosis of T2DM and its careful management may be an important strategy in preserving cognitive function through the lifespan. Given the contrast in results from qualitative and quantitative analysis that we report in the case of midlife cognitive function, we also emphasise the value of combining both methodological approaches where possible.
- 5 December 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (12) , e0327408
Open AccessThe influence of type 2 diabetes and its metabolic correlates in middle-aged adults on cognition at mid and later life; A systematic review and meta-analysis
Introduction: While previous studies have examined the link between Type 2 Diabetes Mellitus (T2DM) and cognitive function in middle-aged adults, no review has explored the long-term effects on cognition of T2DM when diagnosed at midlife. This review aims to investigate any association between T2DM and its metabolic correlates during midlife and measures of cognitive function, spanning from midlife into later life. Methods: Electronic databases (EMBASE, Medline, CINAHL, Web of Science) were explored from their establishment until December 2023 to identify studies exploring the link between T2DM in midlife (40–65 years) and cognitive function. T2DM was defined based on ESC and AHA criteria, encompassing diabetes status, FBG, HbA1c levels, and MetS presence. Cognitive function in mid and/or later life was categorised into functioning sub-domains, with tests selected to reflect predominant cognitive functions utilised. A random-effects meta-analysis was performed, and study quality assessed using the AXIS tool. Results: We included 151 studies of moderate to high quality. Studies were independently screened in a step-by-step process, with a subset of studies that met the criteria selected for inclusion in a meta-analysis. Due to limited availability of raw data for cognitive measures at later life, meta-analysis was conducted on studies assessing cognitive function at midlife only. In the case of later life, the majority of longitudinal studies reported negative relationships between midlife T2DM and cognitive function, specifically in the modalities of executive function and global cognition; findings for memory were conflicting. Qualitive assessment of 107 studies where cognitive function was assessed at midlife found no association between it and midlife T2DM. However, meta-analysis of 10 studies revealed a negative impact of T2DM on memory (MD = −0.19; 95% CI = −0.26 to −0.11; I2 = 25%), executive function (MD = −0.14; 95% CI = −0.25 to −0.04; I2 = 0%), and global cognition (MD = −0.26; 95% CI = −0.34 to −0.17; I2 = 0%). Discussion: This study highlights the impact of midlife T2DM on a variety of cognitive domains from midlife onwards, suggesting that timely diagnosis of T2DM and its careful management may be an important strategy in preserving cognitive function through the lifespan. Given the contrast in results from qualitative and quantitative analysis that we report in the case of midlife cognitive function, we also emphasise the value of combining both methodological approaches where possible.
- Open Access
- 19 March 2025
- Published by Frontiers Media SA in Frontiers in Aging
- Vol. 6, 1430382
The influence of circulating cholesterol and its components in middle-aged adults on cognitive function at mid- and later-life; a systematic review
Introduction: Several measures of cardiovascular health have been investigated as potential risk factors for development of cognitive decline in mid-to later-life, among them, circulating cholesterol. However, the efficacy of midlife interventions aimed at reducing blood cholesterol to mitigate the risk of cognitive decline is uncertain, with conflicting evidence reported from a range of longitudinal and cross-sectional studies. This review systematically investigates the connection between cholesterol measures in midlife and their impact on cognitive function in both mid- and later-life.Methods: Electronic databases were explored from their inception until December 2023. Studies that evaluated the relationship between cholesterol and its sub-components in midlife (40–65 years) and cognitive function in mid and/or later-life were included. Qualitative analysis was used to assess the associations between cholesterol and cognition according to cognitive domains (positive, negative, or neutral).Results: 106 studies were included. We found inconsistent reporting on the association between midlife cholesterol and its sub-components, and cognitive function in older age. Longitudinal cohort studies (75%) generally showed no significant link between midlife cholesterol metrics and later-life cognitive domains. Conversely, half of individual cohort studies (50%) reported negative associations with memory, executive function, global cognition, and psychomotor speed. Most studies (78.6%) found no clear relationship between midlife cholesterol metrics and cognitive function either at midlife or later life, irrespective of study design or quality.Discussion: Our review found no conclusive link between midlife cholesterol and cognitive function in mid- and later-life, contrasting with the recent inclusion of high-LDL cholesterol as a modifiable risk factor for dementia by the 2024 Lancet Commission, following its exclusion in 2020 due to lack of evidence. These conflicting reports highlight the need to continue to investigate the importance of cholesterol metrics at midlife on cognitive function throughout the lifespan. Meanwhile, efforts to manage the all of cognitive decline in mid- and later-life across the population should continue to focus on other modifiable variables.Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD42021238293.
- 19 March 2025
- Published by Frontiers Media SA in Frontiers in Aging
- Vol. 6, 1430382
Open AccessThe influence of circulating cholesterol and its components in middle-aged adults on cognitive function at mid- and later-life; a systematic review
Introduction: Several measures of cardiovascular health have been investigated as potential risk factors for development of cognitive decline in mid-to later-life, among them, circulating cholesterol. However, the efficacy of midlife interventions aimed at reducing blood cholesterol to mitigate the risk of cognitive decline is uncertain, with conflicting evidence reported from a range of longitudinal and cross-sectional studies. This review systematically investigates the connection between cholesterol measures in midlife and their impact on cognitive function in both mid- and later-life.Methods: Electronic databases were explored from their inception until December 2023. Studies that evaluated the relationship between cholesterol and its sub-components in midlife (40–65 years) and cognitive function in mid and/or later-life were included. Qualitative analysis was used to assess the associations between cholesterol and cognition according to cognitive domains (positive, negative, or neutral).Results: 106 studies were included. We found inconsistent reporting on the association between midlife cholesterol and its sub-components, and cognitive function in older age. Longitudinal cohort studies (75%) generally showed no significant link between midlife cholesterol metrics and later-life cognitive domains. Conversely, half of individual cohort studies (50%) reported negative associations with memory, executive function, global cognition, and psychomotor speed. Most studies (78.6%) found no clear relationship between midlife cholesterol metrics and cognitive function either at midlife or later life, irrespective of study design or quality.Discussion: Our review found no conclusive link between midlife cholesterol and cognitive function in mid- and later-life, contrasting with the recent inclusion of high-LDL cholesterol as a modifiable risk factor for dementia by the 2024 Lancet Commission, following its exclusion in 2020 due to lack of evidence. These conflicting reports highlight the need to continue to investigate the importance of cholesterol metrics at midlife on cognitive function throughout the lifespan. Meanwhile, efforts to manage the all of cognitive decline in mid- and later-life across the population should continue to focus on other modifiable variables.Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD42021238293.
- Open Access
- 2 April 2024
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 18, 1399780
Editorial: Insights in learning and memory: 2022
Editorial: Insights in learning and memory: 2022
- 2 April 2024
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 18, 1399780
Open AccessEditorial: Insights in learning and memory: 2022
Editorial: Insights in learning and memory: 2022
- Open Access
- 18 December 2022
- Published by Wiley in The Journal of Physiology
- Vol. 601 (11) , 2069-2083
Exercise‐induced modulation of neuroinflammation in ageing
Optimal performance of the central nervous system (CNS) depends on dynamic, multidirectional communication between different cell types both within and without the CNS to maintain the homeostatic environment. Ageing, in turn, is associated with CNS disequilibrium resulting in suboptimal functioning of its cells and potential cognitive impairment. Emerging evidence indicates that inter‐organ communication influences the functioning of CNS cell types, which are subject to age‐ and environment‐dependent alterations. Endurance exercise has specifically been demonstrated to have a marked impact on neuroimmune communications, particularly those involving microglia, the resident macrophages of the CNS parenchyma, as well as microglia–astrocyte interactions in rodents. Via its action on CNS glial cells, regular aerobic exercise has been shown to provide an adaptive advantage against perturbations to homeostasis, such as immunological challenge or ageing. In light of the accumulating evidence and evolutionary reasoning it may be argued that recurrent exercise‐associated inter‐organ signalling is necessary for the optimisation of glial function and hence CNS equilibrium. This, in turn, would imply that the absence of exercise‐derived mediators and dysregulated inter‐organ communication associated with a sedentary lifestyle may contribute to CNS dyshomeostasis, which is accelerated during ageing. As well as exploring the evidence of the impact of exercise on glial function, here we suggest potential next steps in identifying the mechanistic underpinnings of these effects and the potential importance of sex differences. image
- 18 December 2022
- Published by Wiley in The Journal of Physiology
- Vol. 601 (11) , 2069-2083
Open AccessExercise‐induced modulation of neuroinflammation in ageing
Optimal performance of the central nervous system (CNS) depends on dynamic, multidirectional communication between different cell types both within and without the CNS to maintain the homeostatic environment. Ageing, in turn, is associated with CNS disequilibrium resulting in suboptimal functioning of its cells and potential cognitive impairment. Emerging evidence indicates that inter‐organ communication influences the functioning of CNS cell types, which are subject to age‐ and environment‐dependent alterations. Endurance exercise has specifically been demonstrated to have a marked impact on neuroimmune communications, particularly those involving microglia, the resident macrophages of the CNS parenchyma, as well as microglia–astrocyte interactions in rodents. Via its action on CNS glial cells, regular aerobic exercise has been shown to provide an adaptive advantage against perturbations to homeostasis, such as immunological challenge or ageing. In light of the accumulating evidence and evolutionary reasoning it may be argued that recurrent exercise‐associated inter‐organ signalling is necessary for the optimisation of glial function and hence CNS equilibrium. This, in turn, would imply that the absence of exercise‐derived mediators and dysregulated inter‐organ communication associated with a sedentary lifestyle may contribute to CNS dyshomeostasis, which is accelerated during ageing. As well as exploring the evidence of the impact of exercise on glial function, here we suggest potential next steps in identifying the mechanistic underpinnings of these effects and the potential importance of sex differences. image
- Open Access
- 2 December 2020
- Published by Portland Press Ltd. in Neuronal Signaling
- Vol. 4 (4)
Exercise alters LPS-induced glial activation in the mouse brain
Experimental and epidemiological evidence suggest that modifiable lifestyle factors, including physical exercise, can build structural and cognitive reserve in the brain, increasing resilience to injury and insult. Accordingly, exercise can reduce the increased expression of proinflammatory cytokines in the brain associated with ageing or experimentally induced neuroinflammation. However, the cellular mechanisms by which exercise exerts this effect are unknown, including the effects of exercise on classic or alternative activation of astrocytes and microglia. In the present study, we assess the effects of nine consecutive days of treadmill running on the glial cell response to a single systemic injection of lipopolysaccharide (LPS) and, in parallel, the effects on spatial learning and memory. We show that prior exercise protects against LPS-induced impairment of performance in the object displacement task concomitant with attenuation of IL-1β, TNFα and IL-10 mRNA expression in the hippocampus. Assessment of isolated astrocytes and microglia revealed that LPS induced a proinflammatory response in these cells that was not observed in cells prepared from the brains of mice who had undergone prior exercise. The results suggest that exercise modulates neuroinflammation by reducing the proinflammatory microglial response, suggesting a mechanism by which exercise may be neuroprotective.
- 2 December 2020
- Published by Portland Press Ltd. in Neuronal Signaling
- Vol. 4 (4)
Open AccessExercise alters LPS-induced glial activation in the mouse brain
Experimental and epidemiological evidence suggest that modifiable lifestyle factors, including physical exercise, can build structural and cognitive reserve in the brain, increasing resilience to injury and insult. Accordingly, exercise can reduce the increased expression of proinflammatory cytokines in the brain associated with ageing or experimentally induced neuroinflammation. However, the cellular mechanisms by which exercise exerts this effect are unknown, including the effects of exercise on classic or alternative activation of astrocytes and microglia. In the present study, we assess the effects of nine consecutive days of treadmill running on the glial cell response to a single systemic injection of lipopolysaccharide (LPS) and, in parallel, the effects on spatial learning and memory. We show that prior exercise protects against LPS-induced impairment of performance in the object displacement task concomitant with attenuation of IL-1β, TNFα and IL-10 mRNA expression in the hippocampus. Assessment of isolated astrocytes and microglia revealed that LPS induced a proinflammatory response in these cells that was not observed in cells prepared from the brains of mice who had undergone prior exercise. The results suggest that exercise modulates neuroinflammation by reducing the proinflammatory microglial response, suggesting a mechanism by which exercise may be neuroprotective.
- Open Access
- 11 June 2019
- Published by BMJ in BMJ Open Sport & Exercise Medicine
- Vol. 5 (1) , e000499
Acute high-intensity aerobic exercise affects brain-derived neurotrophic factor in mild cognitive impairment: a randomised controlled study
Objective To investigate the brain-derived neurotrophic factor (BDNF) and cognitive response to a short bout of high-intensity aerobic exercise in older adults with mild cognitive impairment (MCI). Methods Participants were randomised to one of two testing schedules, completing either a standardised exercise test (group A) or a resting control condition (group B). Blood sampling and cognitive measures (visuospatial learning and memory, sustained attention and executive function) were collected at baseline (T1) and postintervention (T2). An additional measurement of study outcomes was collected after exercise (T3) in group B only. Results 64 participants (female 53.2%, mean age 70.5±6.3 years) with MCI were recruited. From T1 to T2, serum BDNF (sBDNF) concentration increased in group A (n=35) (median (Md) 4564.61±IQR 5737.23 pg/mL to Md 5173.27±5997.54 pg/mL) and decreased in group B (Md 4593.74±9558.29 pg/mL to Md 3974.66±3668.22 pg/mL) (between-group difference p=0.024, effect size r=0.3). The control group made fewer errors on the sustained attention task compared with the exercise group (p=0.025). Measures of visuospatial learning and memory or executive function did not change significantly between groups. Conclusion This study is the first to show that a short bout of high-intensity aerobic exercise increases peripheral sBDNF in a population with MCI. However, acute exercise did not improve cognitive performance.
- 11 June 2019
- Published by BMJ in BMJ Open Sport & Exercise Medicine
- Vol. 5 (1) , e000499
Open AccessAcute high-intensity aerobic exercise affects brain-derived neurotrophic factor in mild cognitive impairment: a randomised controlled study
Objective To investigate the brain-derived neurotrophic factor (BDNF) and cognitive response to a short bout of high-intensity aerobic exercise in older adults with mild cognitive impairment (MCI). Methods Participants were randomised to one of two testing schedules, completing either a standardised exercise test (group A) or a resting control condition (group B). Blood sampling and cognitive measures (visuospatial learning and memory, sustained attention and executive function) were collected at baseline (T1) and postintervention (T2). An additional measurement of study outcomes was collected after exercise (T3) in group B only. Results 64 participants (female 53.2%, mean age 70.5±6.3 years) with MCI were recruited. From T1 to T2, serum BDNF (sBDNF) concentration increased in group A (n=35) (median (Md) 4564.61±IQR 5737.23 pg/mL to Md 5173.27±5997.54 pg/mL) and decreased in group B (Md 4593.74±9558.29 pg/mL to Md 3974.66±3668.22 pg/mL) (between-group difference p=0.024, effect size r=0.3). The control group made fewer errors on the sustained attention task compared with the exercise group (p=0.025). Measures of visuospatial learning and memory or executive function did not change significantly between groups. Conclusion This study is the first to show that a short bout of high-intensity aerobic exercise increases peripheral sBDNF in a population with MCI. However, acute exercise did not improve cognitive performance.
- 1 June 2019
- Published by Elsevier in Neuroscience Letters
- Vol. 704, 126-132
An investigation into the relationship between cardiorespiratory fitness, cognition and BDNF in young healthy males
- 1 June 2019
- Published by Elsevier in Neuroscience Letters
- Vol. 704, 126-132
An investigation into the relationship between cardiorespiratory fitness, cognition and BDNF in young healthy males
- 1 February 2019
- Published by Elsevier in Neuropharmacology
- Vol. 145, 1-2
Therapeutic impacts of environmental enrichment: Neurobiological mechanisms informing molecular targets for enviromimetics
- 1 February 2019
- Published by Elsevier in Neuropharmacology
- Vol. 145, 1-2
Therapeutic impacts of environmental enrichment: Neurobiological mechanisms informing molecular targets for enviromimetics
- 1 February 2019
- Published by Elsevier in Neuropharmacology
- Vol. 145, 59-74
Lifelong environmental enrichment in the absence of exercise protects the brain from age-related cognitive decline
- 1 February 2019
- Published by Elsevier in Neuropharmacology
- Vol. 145, 59-74
Lifelong environmental enrichment in the absence of exercise protects the brain from age-related cognitive decline
- 1 November 2018
- Published by Wolters Kluwer Health in Clinical Journal of Sport Medicine
- Vol. 28 (6) , 561-571
Use of Blood Biomarkers in the Assessment of Sports-Related Concussion—A Systematic Review in the Context of Their Biological Significance
Objectives: To critically review current knowledge on the positive and negative predictive value of blood biomarkers for concussion; to illustrate the clinical and biological contexts that help evaluate the use of these markers in sport-related traumatic brain injuries (TBIs). Methods: This systematic review was performed in accordance with PRISMA guidelines. We reviewed the measurement, clinical utility, endpoint, and biological significance of blood biomarkers in concussion. Results: A total of 4352 publications were identified. Twenty-six articles relating to blood biomarkers were included in the review. Four common blood biomarkers, namely S100B, tau, neuron-specific enolase (NSE), and glial fibrillary acidic protein (GFAP), were examined. Overall, the studies showed S100B measurement and use, either acutely or at several time points, can distinguish injured from noninjured patients with an uncertain degree of utility in predicting mortality. At present, S100B has largely become an acceptable biomarker of TBI; however, studies have begun to highlight the need to incorporate clinical symptoms instead of S100B concentration in isolation on the basis of inconsistent results and lack of specificity across published studies. Further research is needed to evaluate and validate the use of tau, NSE, and GFAP as a diagnostic aid in the management of concussion and TBI. Conclusions: At present, blood biomarkers have only a limited role in the evaluation and management of concussion. Although several biomarkers of brain injury have been identified, continued research is required. S100B holds promise as the most clinically useful diagnostic biomarker. Blood biomarkers, in combination with other clinical data, such as head computed tomography, would maximize the diagnostic accuracy. The methodological limitations evident in blood biomarker research results in the need for the clinical utility of blood biomarker use in concussion to be further explored.
- 1 November 2018
- Published by Wolters Kluwer Health in Clinical Journal of Sport Medicine
- Vol. 28 (6) , 561-571
Use of Blood Biomarkers in the Assessment of Sports-Related Concussion—A Systematic Review in the Context of Their Biological Significance
Objectives: To critically review current knowledge on the positive and negative predictive value of blood biomarkers for concussion; to illustrate the clinical and biological contexts that help evaluate the use of these markers in sport-related traumatic brain injuries (TBIs). Methods: This systematic review was performed in accordance with PRISMA guidelines. We reviewed the measurement, clinical utility, endpoint, and biological significance of blood biomarkers in concussion. Results: A total of 4352 publications were identified. Twenty-six articles relating to blood biomarkers were included in the review. Four common blood biomarkers, namely S100B, tau, neuron-specific enolase (NSE), and glial fibrillary acidic protein (GFAP), were examined. Overall, the studies showed S100B measurement and use, either acutely or at several time points, can distinguish injured from noninjured patients with an uncertain degree of utility in predicting mortality. At present, S100B has largely become an acceptable biomarker of TBI; however, studies have begun to highlight the need to incorporate clinical symptoms instead of S100B concentration in isolation on the basis of inconsistent results and lack of specificity across published studies. Further research is needed to evaluate and validate the use of tau, NSE, and GFAP as a diagnostic aid in the management of concussion and TBI. Conclusions: At present, blood biomarkers have only a limited role in the evaluation and management of concussion. Although several biomarkers of brain injury have been identified, continued research is required. S100B holds promise as the most clinically useful diagnostic biomarker. Blood biomarkers, in combination with other clinical data, such as head computed tomography, would maximize the diagnostic accuracy. The methodological limitations evident in blood biomarker research results in the need for the clinical utility of blood biomarker use in concussion to be further explored.